BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38472629)

  • 1. Cerebral Embolic Protection Devices for Transcatheter Aortic Valve Replacement: Review of the Literature and Future Perspectives.
    Ng S; Cunningham T; Vavalle JP
    Curr Cardiol Rep; 2024 May; 26(5):339-347. PubMed ID: 38472629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral embolic protection systems for transcatheter aortic valve replacement.
    Gasior T; Mangner N; Bijoch J; Wojakowski W
    J Interv Cardiol; 2018 Dec; 31(6):891-898. PubMed ID: 30467892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral embolic protection devices during transcatheter aortic valve implantation, the current state of the art.
    Deveci OS; Okutucu S; Fatihoglu SG; Oto A
    Acta Cardiol; 2022 May; 77(3):196-203. PubMed ID: 33827380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Cerebral Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: An Updated Meta-Analysis.
    Kaur A; Dhaliwal AS; Sohal S; Gwon Y; Gupta S; Bhatia K; Dominguez AC; Basman C; Tamis-Holland J
    J Am Heart Assoc; 2024 Feb; 13(3):e030587. PubMed ID: 38240252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral protection devices during transcatheter aortic valve implantation.
    Vlastra W; Vendrik J; Koch KT; Baan J; Piek JJ; Delewi R
    Trends Cardiovasc Med; 2018 Aug; 28(6):412-418. PubMed ID: 29428159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.
    Seeger J; Gonska B; Otto M; Rottbauer W; Wöhrle J
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2297-2303. PubMed ID: 28917515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement.
    Latib A; Mangieri A; Vezzulli P; Spagnolo P; Sardanelli F; Fellegara G; Pagnesi M; Giannini F; Falini A; Gorla R; Montorfano M; Bedogni F; Colombo A; Popma J; Merhi WM; De Marco F
    JACC Cardiovasc Interv; 2020 Apr; 13(7):860-868. PubMed ID: 32273098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection from Cerebral Embolic Events During Transcatheter Aortic Valve Replacement.
    Rossow CF; McCabe JM
    Curr Cardiol Rep; 2016 Feb; 18(2):16. PubMed ID: 26768742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement.
    Van Gils L; Kroon H; Daemen J; Ren C; Maugenest AM; Schipper M; De Jaegere PP; Van Mieghem NM
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):790-797. PubMed ID: 28895285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Capturing Debris during TAVR Prevent Strokes?
    Carroll JD; Saver JL
    N Engl J Med; 2022 Oct; 387(14):1318-1319. PubMed ID: 36121036
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Outcome of Transcatheter Aortic Valve Replacement With TriGUARD 3™ Cerebral Embolic Protection Device.
    Daal SM; Jimenez-Rodriguez GMJ; Voskuil M; Kraaijeveld AO; Dessing TC; Ramjankhan FZ; Mokhles MM; Stella PR
    Cardiovasc Revasc Med; 2023 May; 50():8-12. PubMed ID: 36681530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Outcomes of Sentinel Cerebral Protection System Use During Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.
    Ndunda PM; Vindhyal MR; Muutu TM; Fanari Z
    Cardiovasc Revasc Med; 2020 Jun; 21(6):717-722. PubMed ID: 31175048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcarotid transcatheter aortic valve replacement with cerebral embolic protection.
    McGrath D; Salehi P; Weintraub A; Zhan Y
    J Card Surg; 2022 Jun; 37(6):1779-1782. PubMed ID: 35301761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During Transcatheter Aortic Valve Replacement.
    Schmidt T; Leon MB; Mehran R; Kuck KH; Alu MC; Braumann RE; Kodali S; Kapadia SR; Linke A; Makkar R; Naber C; Romero ME; Virmani R; Frerker C
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1262-1273. PubMed ID: 29976363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Cerebral Embolic Protection Devices on Characteristics and Outcomes of Stroke Complicating TAVR.
    Levi A; Linder M; Seiffert M; Witberg G; Pilgrim T; Tomii D; Barkan YT; Van Mieghem NM; Adrichem R; Codner P; Hildick-Smith D; Arunothayaraj S; Perl L; Finkelstein A; Loewenstein I; De Backer O; Barnea R; Tarantini G; Fovino LN; Vaknin-Assa H; Mylotte D; Wagener M; Webb JG; Akodad M; Colombo A; Mangieri A; Latib A; Kargoli F; Giannini F; Ielasi A; Søndergaard L; Aviram I; Lerman TT; Kheifets M; Auriel E; Kornowski R;
    JACC Cardiovasc Interv; 2024 Mar; 17(5):666-677. PubMed ID: 38479966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Clinical Impact of Cerebral Embolic Protection in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Kroon HG; van der Werf HW; Hoeks SE; van Gils L; van den Berge FR; El Faquir N; Rahhab Z; Daemen J; Poelman J; Schurer RAJ; van den Heuvel A; de Jaegere P; van der Harst P; Van Mieghem NM
    Circ Cardiovasc Interv; 2019 Jun; 12(6):e007605. PubMed ID: 31195822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological Outcomes With Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Giustino G; Mehran R; Veltkamp R; Faggioni M; Baber U; Dangas GD
    JACC Cardiovasc Interv; 2016 Oct; 9(20):2124-2133. PubMed ID: 27765306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis.
    Seeger J; Kapadia SR; Kodali S; Linke A; Wöhrle J; Haussig S; Makkar R; Mehran R; Rottbauer W; Leon M
    Eur Heart J; 2019 May; 40(17):1334-1340. PubMed ID: 30590554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of cerebral protection devices in transcatheter aortic valve replacement: A clinical end-points meta-analysis.
    Mohananey D; Sankaramangalam K; Kumar A; Jobanputra Y; Villablanca P; Krishnaswamy A; Mick S; Svensson LG; Tuzcu EM; Kapadia SR
    Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):785-791. PubMed ID: 29550047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral embolic protection during transcatheter aortic valve replacement: a systematic review and meta-analysis of propensity score matched and randomized controlled trials using the Sentinel cerebral embolic protection device.
    Wolfrum M; Handerer IJ; Moccetti F; Schmeisser A; Braun-Dullaeus RC; Toggweiler S
    BMC Cardiovasc Disord; 2023 Jun; 23(1):306. PubMed ID: 37330463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.